Avid Bioservices Gross Profit

Avid Bioservices (CDMO) currently reports a gross profit of $12M as of October 2024. That compares with $18M in the prior-year period — down 34.6% year over year. That is below the Healthcare sector average of $65B. Use the charts on this page to explore Avid Bioservices's gross profit history and peer comparisons.

Avid Bioservices's gross profit decreased from $18M to $12M — a 34.6% year-over-year decrease (period ending October 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Avid Bioservices's gross profit of $12M is lower than the Healthcare sector average of $65B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Avid Bioservices reported $12M in gross profit as of October 2024. That compares with $18M in the prior-year period — down 34.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $65B. From there, open related valuation or income-statement pages for Avid Bioservices, and consider following CDMO for alerts when major investors trade the stock.